Prof. Dr. Berrin Pehlivan

Prof. Dr. Berrin Pehlivan

Radyasyon Onkolojisi - İstanbul

Randevu takvimi talep edin

Adresler (1)

Levent Mahallesi Krizantem Sokak No:30 Levent İstanbul

Prof Dr Berrin Pehlivan Muayenehanesi

Bu kliniğin online randevu alabileceğiniz bir takvimi bulunmuyor.

Prof. Dr. Berrin Pehlivan Hakkında

Prof. Dr. Berrin Pehlivan Kimdir?

Prof. Dr. Berrin Pehlivan, Hacettepe Üniversitesi Tıp Fakültesi mezunu… Aile ve çevresinde sıklıkla rastladığı Kanser vakalarının motivasyonuyla On...

  • Daha Fazla
    • İlgilendiği Hastalıklar
    • Göğüs Kanseri
    • Baş Ve Boyun Kanserleri
    • Pediatrik Tümörler
    • Gastrointestinal Sistem Tümörü (GIST)
    • Tümünü Göster
    Tedaviler
    • Randevu
    • Ameliyatsız Prostat Kanseri Tedavisi
    • Brakiterapi
    • Eksternal radyoterapi
    • Tümünü Göster
    Yabancı Diller
    • İngilizce,
    • Fransızca
    Yayınlar
    • Pehlivan B, Topkan E, Onal C, Nursal GN, Yüksel O, Yavuz M, Yavuz A.: Comparison of CT and integrated PET-CT based radiation therapy planning in malign plevral mesothelioma patients. Radiat Oncol. 2009, 4:35.
    • Pehlivan B, Luthi F, Matzinger O, Betz M, Dragusanu D, Bulling S, Bron L, Pasche P, Seelentag W, Mirimanoff RO, Zouhair A, Ozsahin M.: Feasibility and efficacity of accelerated weekly concomitant boost postopeartive radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer. Ann Surg Oncol. 2009, 16:1337-1343.
    • Pehlivan B, Pichenot C, Casting M, Auperin A, Arriagada R, Bourhis J.: Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients. Acta Oncol. 2009, 48(3):440-5.
    • Pehlivan B, Zouhair A, Luthi F, Bron L, Pasche P, Dragusanu D, Azria D, Matzinger O, Mirimanoff RO, Ozsahin M.: Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy. Ann Surg Oncol. 2009, 16:1331-1336.
    • Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Matzinger O, Zouhair A.: Outcome and prognostıc factors ın olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys. 20100Nov 15;78(4):992-7.
    • Atahan IL, Yıldız F, Ozyar E, Pehlivan B, Genç M, Köse M, Tulunay G, Ayhan A, Yuce K, Güler N, Kucukali T.: Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors. Int J Gynecol Cancer 2007, 17 (4): 813-820.
    • Onal C, Arslan G, Topkan E, Pehlivan B, Yavuz M, Oymak E, Yavuz A.: Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009 Jul 1;28:95.
    • Yavuz MN, Topkan E, Yavuz AA, Aydin M, Onal C, Reyhan M, Kotek A, Pehlivan B, Yapar AF.: FDG-PET/CT Imaging-based taget volume delineation for preoperative conformal radiotherapy for rectal carcinoma. Int J Hematol Oncol 2010, 20(2):067-074.
    • Garcia R, Bourhis J, Pehlivan B, Pichenot C, Alfonsi M.: Intensity modulated radiotherapy for cancers of the upper aerodigestive tract. Cancer Radiother 2007, 11(6-7):353-7.
    • Pehlivan B, Yavuz M, Gonlusen G, Erbay A, Yavuz A, Onal C, Topkan E, Sarialioglu F.: PET-CT–Based 3-D Conformal Radiation Therapy in the Aggressive Ostoblastoma: A Case Report. Int J Hematol Oncol (Baskıda).
    • Pehlivan B, Onal C, Yavuz M.: Retinoblastoma tedavisinde eksternal radyoterapinin rolü ve Radyoterapi seçenekleri. Int J Hematol Oncol (Baskıda).
    • Onal C, Pehlivan B, Bal N, Topkan E, Kilinc F, Topuk S. : Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report. Clinical Medicine: Case Reports 2009:239-42.
    • Onal C, Yuksel O, Topkan E, Pehlivan B. : Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: case report. Cases Journal 2009, 2:8402.
    • Sarıca F, Tufan K, Çekinmez M, Şen O, Onal HC, Mertsoylu H, Pehlivan B, Erdoğan B, Altınors MN. Effectiveness of temozolomidetreatment used at thesame time with radiotherapyand adjuvant temozolomid: concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors. J Neurosurg Sci. 2010; 54(1): 7-19.
    • Topkan E, Topuk S, Oymak E, Parlak C, Pehlivan B. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. Am J Clin Oncol 2011 Epub ahead of print.
    • Topkan E, Parlak C, Kotek A, Yapar AF, Pehlivan B. Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. BMC Gastroenterol 201110,11:123.
    • Topkan E, Parlak C, Kotek A, Yuksel O, Cengiz M, Ozsahin M, Pehlivan B. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens. Int J Radiat Oncol Biol Phys 2012 July 15;83(4):1264-71.
    • Pehlivan B, Ares C, Lomax T, Stadelmann O, Goitein G, Timmermann B, Schneider RA, Hug EB.: Temporal lobe toxicity analyasis after proton radiation therapy for skull base tumors. Int J Radiat Oncol Biol Phys 2012 Aug 1;83(5):1432-40.
    • Topkan E. Parlak C, Topuk S, Pehlivan B. Influence on oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. BMC Cancer 2012 Oct 31;12:502
    • Sarıca FB, Cekinmez M, Tufan K, Sen O, Onal HC, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Altinors B. Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and efeectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma. Asian J Neurosurg. 2012 Oct;7(4):181-90.
    • Mirimanoff RO, Ozsahin M, Thariat J, Ozyar E, Schick U, Pehlivan B, Krengli M, Pellanda AF, Vees H, Cai L, Scandolaro L, Belkacemi Y, Villa S, İgdem S, Lutsyk M, Miller RC. History of the rare cancer network and past research. Rare Tumors. 2014 Aug6;6(3):5462.
    • Topkan E, Yildirim BA, Guler OC, Parlak C, Pehlivan B, Selek U. Safety and palliative efficacy of single-dose-8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):774-80.

    Değerlendirmeler

    Değerlendir

    Hizmetler

    İlgilendiği Hastalıklar
    • Göğüs Kanseri
    • Baş Ve Boyun Kanserleri
    • Pediatrik Tümörler
    • Gastrointestinal Sistem Tümörü (GIST)
    • Jinekolojik Tümörler
    • Ürolojik Tümörler
    • Akciğer Kanseri
    • Prostat Kanseri
    • Lenfoma
    • Beyin Tümörleri
    • Jinekolojik Kanserler
    • Non Hodkin Lenfoma
    • Vajen Ca
    • Lenfoma
    • Böbrek hastalığı
    • Rektum Kanseri
    • Adenokarsinom
    • Nazofarenks
    • Gastrointestinal Sistem Kanserleri
    • Hematopoeitik Sistem Tümörleri
    • Testis Kanseri
    • Multiple Myeloma
    • Rahim Ağzı Kanseri
    • Kanser
    • Kolon Kanseri
    • Gırtlak (Larenks) Kanseri
    • Deri Kanseri
    • Baş Ağrıları
    • Beyin Hastalıkları
    • Mide Kanseri
    • Kolon Ca
    • Göğüs Kanseri
    • Ur (tümör)
    • Prostat Yangılanması
    • Rahim İltihabı
    • Akciğer Kanseri
    • Radyason Onkolojisi
    Tedaviler
    • Randevu
    • Ameliyatsız Prostat Kanseri Tedavisi
    • Brakiterapi
    • Eksternal radyoterapi
    • Kanser görüntüleme kanser deteksiyonu
    • Protonterapi
    • Radyocerrahi
    • Radyoterapi
    • Stereotaktik radyocerrahi (SRS)
    • Stereotaktik Radyoterapi (SRT)
    • Tomoterapi
    • Yogunluk Ayarlı Radyoterapi (IMRT)
    • İnternal Radyoterapi

    Prof. Dr. Berrin Pehlivan Hakkında

    Prof. Dr. Berrin Pehlivan Kimdir?

    Prof. Dr. Berrin Pehlivan, Hacettepe Üniversitesi Tıp Fakültesi mezunu… Aile ve çevresinde sıklıkla rastladığı Kanser vakalarının motivasyonuyla On...

    Daha Fazla
    İlgilendiği Hastalıklar
    • Göğüs Kanseri
    • Baş Ve Boyun Kanserleri
    • Pediatrik Tümörler
    • Gastrointestinal Sistem Tümörü (GIST)
    • Tümünü Göster
    Tedaviler
    • Randevu
    • Ameliyatsız Prostat Kanseri Tedavisi
    • Brakiterapi
    • Eksternal radyoterapi
    • Tümünü Göster
    Yabancı Diller
    • İngilizce,
    • Fransızca
    Yayınlar
    • Pehlivan B, Topkan E, Onal C, Nursal GN, Yüksel O, Yavuz M, Yavuz A.: Comparison of CT and integrated PET-CT based radiation therapy planning in malign plevral mesothelioma patients. Radiat Oncol. 2009, 4:35.
    • Pehlivan B, Luthi F, Matzinger O, Betz M, Dragusanu D, Bulling S, Bron L, Pasche P, Seelentag W, Mirimanoff RO, Zouhair A, Ozsahin M.: Feasibility and efficacity of accelerated weekly concomitant boost postopeartive radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer. Ann Surg Oncol. 2009, 16:1337-1343.
    • Pehlivan B, Pichenot C, Casting M, Auperin A, Arriagada R, Bourhis J.: Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients. Acta Oncol. 2009, 48(3):440-5.
    • Pehlivan B, Zouhair A, Luthi F, Bron L, Pasche P, Dragusanu D, Azria D, Matzinger O, Mirimanoff RO, Ozsahin M.: Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy. Ann Surg Oncol. 2009, 16:1331-1336.
    • Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Matzinger O, Zouhair A.: Outcome and prognostıc factors ın olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys. 20100Nov 15;78(4):992-7.
    • Atahan IL, Yıldız F, Ozyar E, Pehlivan B, Genç M, Köse M, Tulunay G, Ayhan A, Yuce K, Güler N, Kucukali T.: Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors. Int J Gynecol Cancer 2007, 17 (4): 813-820.
    • Onal C, Arslan G, Topkan E, Pehlivan B, Yavuz M, Oymak E, Yavuz A.: Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009 Jul 1;28:95.
    • Yavuz MN, Topkan E, Yavuz AA, Aydin M, Onal C, Reyhan M, Kotek A, Pehlivan B, Yapar AF.: FDG-PET/CT Imaging-based taget volume delineation for preoperative conformal radiotherapy for rectal carcinoma. Int J Hematol Oncol 2010, 20(2):067-074.
    • Garcia R, Bourhis J, Pehlivan B, Pichenot C, Alfonsi M.: Intensity modulated radiotherapy for cancers of the upper aerodigestive tract. Cancer Radiother 2007, 11(6-7):353-7.
    • Pehlivan B, Yavuz M, Gonlusen G, Erbay A, Yavuz A, Onal C, Topkan E, Sarialioglu F.: PET-CT–Based 3-D Conformal Radiation Therapy in the Aggressive Ostoblastoma: A Case Report. Int J Hematol Oncol (Baskıda).
    • Pehlivan B, Onal C, Yavuz M.: Retinoblastoma tedavisinde eksternal radyoterapinin rolü ve Radyoterapi seçenekleri. Int J Hematol Oncol (Baskıda).
    • Onal C, Pehlivan B, Bal N, Topkan E, Kilinc F, Topuk S. : Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report. Clinical Medicine: Case Reports 2009:239-42.
    • Onal C, Yuksel O, Topkan E, Pehlivan B. : Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: case report. Cases Journal 2009, 2:8402.
    • Sarıca F, Tufan K, Çekinmez M, Şen O, Onal HC, Mertsoylu H, Pehlivan B, Erdoğan B, Altınors MN. Effectiveness of temozolomidetreatment used at thesame time with radiotherapyand adjuvant temozolomid: concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors. J Neurosurg Sci. 2010; 54(1): 7-19.
    • Topkan E, Topuk S, Oymak E, Parlak C, Pehlivan B. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. Am J Clin Oncol 2011 Epub ahead of print.
    • Topkan E, Parlak C, Kotek A, Yapar AF, Pehlivan B. Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. BMC Gastroenterol 201110,11:123.
    • Topkan E, Parlak C, Kotek A, Yuksel O, Cengiz M, Ozsahin M, Pehlivan B. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens. Int J Radiat Oncol Biol Phys 2012 July 15;83(4):1264-71.
    • Pehlivan B, Ares C, Lomax T, Stadelmann O, Goitein G, Timmermann B, Schneider RA, Hug EB.: Temporal lobe toxicity analyasis after proton radiation therapy for skull base tumors. Int J Radiat Oncol Biol Phys 2012 Aug 1;83(5):1432-40.
    • Topkan E. Parlak C, Topuk S, Pehlivan B. Influence on oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. BMC Cancer 2012 Oct 31;12:502
    • Sarıca FB, Cekinmez M, Tufan K, Sen O, Onal HC, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Altinors B. Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and efeectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma. Asian J Neurosurg. 2012 Oct;7(4):181-90.
    • Mirimanoff RO, Ozsahin M, Thariat J, Ozyar E, Schick U, Pehlivan B, Krengli M, Pellanda AF, Vees H, Cai L, Scandolaro L, Belkacemi Y, Villa S, İgdem S, Lutsyk M, Miller RC. History of the rare cancer network and past research. Rare Tumors. 2014 Aug6;6(3):5462.
    • Topkan E, Yildirim BA, Guler OC, Parlak C, Pehlivan B, Selek U. Safety and palliative efficacy of single-dose-8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):774-80.

    Değerlendirmeler

    Değerlendir

    Hasta Soruları

    Soru Sor

    Görüntülü GörüşmeÇevrimiçi

    Randevu Alın

    Bu uzmanın online randevu alabileceğiniz bir takvimi bulunmuyor.

    Randevu takvimi talep edin